Prednisolone may be effective in restoring A-V nodal conduction in patients with complete A-V block caused by idiopathic giant cell myocarditis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for steroid use in giant cell myocarditis AV block; leaves open need for controlled confirmation before practice change.
Giant cell myocarditis (GCM) is a rapidly progressive disease that leads to ventricular tachycardia or high-grade atrioventricular (A-V) block, frequently requiring a pacemaker. A 64-year-old woman developed syncope as a result of idiopathic GCM with A-V block. She required both a temporary and a permanent pacemaker. Two-dimensional echocardiography showed severely reduced wall motion. There was no histologic or clinical evidence to suggest sarcoidosis. Despite treatment with diuretics and an angiotensin-converting enzyme inhibitor, exertional dyspnea persisted. She received prednisolone 4 months after the onset of complete A-V block in the late phase of GCM. Prednisolone improved A-V nodal conduction in spite of the fact that there was no influence from LV wall motion, and sinus rhythm has continued for more than 2 years. In this patient, prednisolone was effective in the treatment of GCM.
No takes yet. Share an insight, caveat, or question.
Hanawa et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: